Clover Biopharmaceuticals Revenue and Competitors

Clover Biopharmaceuticals is a clinical-stage global biotechnology company committed to developing transformative biologics as vaccines and therapeutics for the world's most debilitating diseases. With a foundation of scientific excellence and world-class expertise, the Clover team leverages our proprietary Trimer-Tag© technology and fully integrated manufacturing capabilities to discover, develop and deliver innovative and affordable medical solutions for people living with infectious diseases, cancer and autoimmune diseases around the world. Founded in China, we are committed to addressing the most urgent healthcare need facing the local and global communities. Every day, we transform our first-class science into breakthrough medicines for patients with the greatest unmet need. We pledge to adhere to the highest scientific and ethical standards, and we strive to pave the way to a healthier future. Having raised more than USD $350 million in total capital since 2016, Clover strives to become a leading innovative biotechnology company with its diverse global team, robust R&D pipeline, large-scale in-house manufacturing capabilities and strong partnerships with renowned healthcare organizations. Our goal is to provide brand new medicines with the potential to transform healthcare paradigms and improve the quality of life for patients all around the world.